NASDAQ:SLGL

Sol-Gel Technologies Q1 2026 Earnings Results & Report

Sol-Gel Technologies logo
$52.83 -2.13 (-3.88%)
Closing price 04:00 PM Eastern
Extended Trading
$52.56 -0.27 (-0.51%)
As of 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Sol-Gel Technologies beat analyst earnings expectations but missed on revenue in its Q1 2026 results, released May 28, 2026. The company reported EPS of -$1.31 versus the -$2.86 consensus estimate, while revenue of $108 thousand fell short of the $900 thousand estimate by $792 thousand.

Earnings Announcement Details

Quarter
Q1 2026
Report Date
Time
Before Market Opens
Conference Call
8:00 AM ET

Sol-Gel Technologies EPS Results

Actual EPS
-$1.31
Consensus EPS
-$2.86
Beat/Miss
Beat by +$1.55
One Year Ago EPS
N/A
EPS Beat Rate
5 of last 8 quarters

Sol-Gel Technologies Revenue Results

Actual Revenue
$108 thousand
Expected Revenue
$900 thousand
Beat/Miss
Missed by -$792.00 thousand
YoY Revenue Growth
N/A

Earnings Documents

Sol-Gel Technologies Q1 2026 Earnings FAQ

Sol-Gel Technologies (NASDAQ:SLGL) reported earnings of -$1.31 per share for Q1 2026, beating the consensus estimate of -$2.86. The report was announced on Thursday, May 28, 2026.

Sol-Gel Technologies reported revenue of $108 thousand for Q1 2026, against a consensus estimate of $900 thousand.

Sol-Gel Technologies Earnings Headlines

Contrasting Sol-Gel Technologies (SLGL) & Its Rivals
Your book is inside
The "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. They don't know the rules. They don't know what to avoid. And they hand their account to Wall Street on a silver platter. Normally $29.97. Free today.tc pixel
Sol-Gel Technologies (SLGL) Projected to Release Earnings on Thursday
See More Sol-Gel Technologies Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Sol-Gel Technologies? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Sol-Gel Technologies and other key companies, straight to your email.

About Sol-Gel Technologies

Sol-Gel Technologies (NASDAQ:SLGL) is an Israel-based dermatology company that develops topical treatments for skin conditions. Its proprietary technology uses silica-based microencapsulation to formulate active ingredients for topical use.

The company’s products include Epsolay, a benzoyl peroxide cream approved in the United States for inflammatory lesions of rosacea, and Twyneo, a topical combination of tretinoin and benzoyl peroxide approved for acne vulgaris.

Sol-Gel has pursued commercialization and licensing opportunities in the United States and other markets. Its business also includes developing additional dermatology treatments using its formulation platform.

View Sol-Gel Technologies Profile